VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 101 filers reported holding VERVE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $9,375,000 | -45.8% | 500,000 | -58.3% | 0.72% | -36.6% |
| Q1 2023 | $17,304,000 | -1.8% | 1,200,000 | +31.7% | 1.14% | +3.7% |
| Q4 2022 | $17,629,998 | -43.7% | 911,111 | 0.0% | 1.10% | -26.2% |
| Q3 2022 | $31,297,000 | +120.9% | 911,111 | -1.7% | 1.49% | +113.8% |
| Q2 2022 | $14,166,000 | -17.2% | 927,100 | +23.6% | 0.70% | -22.7% |
| Q1 2022 | $17,115,000 | -33.7% | 750,000 | +7.1% | 0.90% | -26.1% |
| Q4 2021 | $25,809,000 | -8.5% | 700,000 | +16.7% | 1.22% | -16.2% |
| Q3 2021 | $28,200,000 | -41.0% | 600,000 | -24.4% | 1.46% | -31.2% |
| Q2 2021 | $47,794,000 | – | 793,265 | – | 2.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alphabet Inc. | 10,974,011 | $515,778,000 | 12.24% |
| Casdin Capital, LLC | 3,038,167 | $142,794,000 | 3.55% |
| Redmile Group, LLC | 1,869,030 | $87,844,000 | 1.53% |
| Logos Global Management LP | 443,265 | $20,833,000 | 1.50% |
| Novo Holdings A/S | 600,000 | $28,200,000 | 1.46% |
| Cormorant Asset Management, LP | 709,224 | $32,667,000 | 1.33% |
| Rock Springs Capital Management LP | 962,826 | $45,253,000 | 0.95% |
| HighVista Strategies LLC | 18,782 | $883,000 | 0.58% |
| RA Capital Management | 880,284 | $41,373,000 | 0.57% |
| Nicholas Investment Partners, LP | 132,300 | $6,218,000 | 0.45% |